对HNSCC瘤异质性和编程细胞死亡途径的单细胞洞察力
Yuanhao Chai1, Jianlin Zhang2, Wenwen Shao3
1Department of Plastic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; University of Southern California, Los Angeles, USA.
Translational oncology
|March 11, 2025
概括
单细胞测序揭示了不同的头部和部状细胞癌 (HNSCC) 亚种群. MALAT1+瘤亚群显示了改变的途径,并预测了患者的存活率,为HNSCC提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 头部和部状细胞癌 (HNSCC) 具有显著的死亡率和复发风险,通常在晚期被诊断出来.
- 了解HNSCC异质性对于改善治疗策略和患者治疗结果至关重要.
研究的目的:
- 使用单细胞RNA测序 (scRNA-seq) 调查HNSCC瘤亚群.
- 在HNSCC中识别新的预后标记和治疗点.
- 完善头部和部状细胞癌的预后模型.
主要方法:
- 对HNSCC瘤亚种群进行了伪形状轨迹和茎状分析.
- 在不同的子群体中检查了编程死亡和代谢途径.
- 使用LASSO回归和MALAT1瘤风险评分 (MTRS) 开发了一个预后模型.
主要成果:
- 在C2 MALAT1+ 瘤亚群中,编程死亡和代谢途径的表达减少.
- 关键的转录因子 (LEF1,RFX3,CREM,MZF1,ZNF202) 和风险基因 (ADM,RPL31,EIF5B,TAF7) 被确定.
- 高的MTRS与更差的生存率,更高的瘤纯度,丰富的CD4记忆T细胞和对特定化疗的敏感性增加相关.
结论:
- ScRNA-seq阐明了HNSCC的异质性,特别是C2 MALAT1+瘤亚群.
- 确定了新的预后标记物和治疗点,进步了对HNSCC进展和耐药性的理解.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


